Fundraising Fox
Inari Medical Inc.
also invests · investor profileIrvine, US · Founded 2011 · Delaware corporation · 618 employees on LinkedIn · 4 known investors
Find your way into Inari Medical Inc.
2,272 people in our graph can introduce you to the Inari Medical Inc. team.
Sign up to see every warm intro you have to Inari Medical Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Inari Medical Inc. team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Inari Medical develops mechanical thrombectomy devices for treating venous thromboembolism conditions, including pulmonary embolism, deep vein thrombosis, in-stent thrombosis, and arteriovenous fistula thrombosis. Its product portfolio includes the FlowTriever and ClotTriever systems, catheters, and blood return systems used by clinicians treating vascular blood clots.
Founders & leadership
Board
Investors · 4
How we know: Gilde Healthcare's portfolio page · funding news · fiercebiotech.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: US Venture Partners's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: funding news · fiercebiotech.com · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$45.5M disclosed across 3 rounds · 2015–2018
▶$27MraisedApr 2018 · 20 investors · Other Health CareRule 506(b)
- Donald MilderDirector
- Robert RosenbluthExecutive Officer, Director
- William H. HoffmanExecutive Officer, Director
- Brian CoxDirector
- Kirk NielsenDirector
- Jonathan RootDirector
- Paul LubockDirector
- Offering amount
- $27M
- Amount sold
- $27M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.1MraisedDec 2015 · 5 investors · Other Health CareRule 506(b)
- Paul LubockDirector
- William H. HoffmanExecutive Officer, Director
- Kirk NielsenDirector
- Brian CoxDirector
- Donald MilderDirector
- Robert RosenbluthExecutive Officer, Director
- Jonathan RootDirector
- Offering amount
- $6.1M
- Amount sold
- $6.1M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
▶$12.4MraisedJul 2015 · 24 investors · Other Health CareRule 506(b)
- Robert RosenbluthExecutive Officer, Director
- William H. HoffmanExecutive Officer, Director
- Brian CoxDirector
- Donald MilderDirector
- Paul LubockDirector
- Kirk NielsenDirector
- Jonathan RootDirector
- Offering amount
- $12.4M
- Amount sold
- $12.4M
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
Companies working in the same space as Inari Medical Inc..
In the news
Frequently asked questions
- What does Inari Medical Inc. do?
- Inari Medical develops mechanical thrombectomy devices for treating venous thromboembolism conditions, including pulmonary embolism, deep vein thrombosis, in-stent thrombosis, and arteriovenous fistula thrombosis. Its product portfolio includes the FlowTriever and ClotTriever systems, catheters, and blood return systems used by clinicians treating vascular blood clots.
- Who are Inari Medical Inc.'s investors?
- Inari Medical Inc.'s investors include Gilde Healthcare, US Venture Partners, Vensana Capital, Versant Ventures.
- How much funding has Inari Medical Inc. raised?
- Inari Medical Inc. has disclosed $45.5M raised across 3 rounds.
- Where is Inari Medical Inc. headquartered?
- Inari Medical Inc. is headquartered in Irvine, US.